Skip to main content
Top
Published in: Journal of Translational Medicine 1/2018

Open Access 01-12-2018 | Correction

Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma

Authors: Alexander W. Eckert, Claudia Wickenhauser, Paul C. Salins, Matthias Kappler, Juergen Bukur, Barbara Seliger

Published in: Journal of Translational Medicine | Issue 1/2018

Login to get access

Excerpt

The original version of this article [1], published on 5 April 2016, contains a mistake. In the ‘Role of pH stabilisation’ section, “intracellular pH” has been incorrectly abbreviated as “pHe”. The correct abbreviation is “pHi”. The affected sentence with the correct abbreviation is given below.
  • The metabolic adaption accumulates different ionic exchangers at the tumor cell membrane to maintain intracellular pH (pHi) (Fig. 2).
Metadata
Title
Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
Authors
Alexander W. Eckert
Claudia Wickenhauser
Paul C. Salins
Matthias Kappler
Juergen Bukur
Barbara Seliger
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2018
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-018-1407-9

Other articles of this Issue 1/2018

Journal of Translational Medicine 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.